Scholarlink

Background <p>As trypsin activation occurs early in the pathogenesis of pancreatitis, evaluating serum trypsin (TRY) may allow immediate prediction of post-ERCP pancreatitis (PEP). This study aims to evaluate the diagnostic performance of TRY measurement for predicting PEP.</p> Methods <p>This multicenter prospective observational study was conducted at 12 tertiary centers in Japan. Serum TRY, amylase (AMY), pancreatic-type AMY (P-AMY), and lipase (LIP) were measured before ERCP, immediately post-procedure (0&#xa0;h), and 2&#xa0;h post-procedure. Predictive performances of pancreatic enzymes for PEP were evaluated using receiver operating characteristic (ROC) analysis, Youden’s index, and DeLong’s test.</p> Results <p>PEP was identified in 48 of the 463 patients analyzed (10.3%). The optimal 0-h TRY cut-off was 2043&#xa0;ng/mL, yielding an area under the ROC curve (AUC) of 0.83 (68.7% sensitivity, 84.6% specificity), significantly higher than those of 0-h AMY (AUC 0.74, <i>p</i> = 0.002), 0-h P-AMY (0.78, <i>p</i> = 0.007), or 0-h LIP (0.80, <i>p</i> = 0.048). At 2-h, TRY showed an AUC of 0.89, superior to 2-h&#xa0;AMY (0.84) and comparable to 2-h&#xa0;P-AMY (0.89) and 2-h&#xa0;LIP (0.90). When cutoffs were set as 2 × , 2.5 × and 3 × of the upper limit of normal, TRY consistently showed higher sensitivity than AMY or P-AMY. TRY showed the earliest and steepest post-procedural increase among all enzymes in patients with PEP.</p> Conclusions <p>TRY measured immediately after ERCP provides significantly better early prediction of PEP than conventional enzymes. Rapid measurement of TRY may enable immediate risk stratification, potentially improving clinical outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immediate prediction of post-ERCP pancreatitis: a novel approach using serum trypsin

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月7日

查看全文
  • Takashi Tamura,
  • Seiji Fujigaki,
  • Tsuyoshi Sanuki,
  • Tetsuya Ikeda,
  • Satoshi Sugimori,
  • Tsukasa Ikeura,
  • Shinji Nakayama,
  • Tomoya Emori,
  • Kazuhiro Fukatsu,
  • Yasutaka Ishii,
  • Shiro Oka,
  • Kenji Ikezawa,
  • Ryoji Takada,
  • Masanori Asada,
  • Ayana Kishibuchi,
  • Takeshi Ogura,
  • Nobu Nishioka,
  • Masaaki Shimatani,
  • Masataka Kano,
  • Arata Sakai,
  • Kae Nagao,
  • Shuhei Shintani,
  • Osamu Inatomi,
  • Masayuki Kitano

摘要

Background

As trypsin activation occurs early in the pathogenesis of pancreatitis, evaluating serum trypsin (TRY) may allow immediate prediction of post-ERCP pancreatitis (PEP). This study aims to evaluate the diagnostic performance of TRY measurement for predicting PEP.

Methods

This multicenter prospective observational study was conducted at 12 tertiary centers in Japan. Serum TRY, amylase (AMY), pancreatic-type AMY (P-AMY), and lipase (LIP) were measured before ERCP, immediately post-procedure (0 h), and 2 h post-procedure. Predictive performances of pancreatic enzymes for PEP were evaluated using receiver operating characteristic (ROC) analysis, Youden’s index, and DeLong’s test.

Results

PEP was identified in 48 of the 463 patients analyzed (10.3%). The optimal 0-h TRY cut-off was 2043 ng/mL, yielding an area under the ROC curve (AUC) of 0.83 (68.7% sensitivity, 84.6% specificity), significantly higher than those of 0-h AMY (AUC 0.74, p = 0.002), 0-h P-AMY (0.78, p = 0.007), or 0-h LIP (0.80, p = 0.048). At 2-h, TRY showed an AUC of 0.89, superior to 2-h AMY (0.84) and comparable to 2-h P-AMY (0.89) and 2-h LIP (0.90). When cutoffs were set as 2 × , 2.5 × and 3 × of the upper limit of normal, TRY consistently showed higher sensitivity than AMY or P-AMY. TRY showed the earliest and steepest post-procedural increase among all enzymes in patients with PEP.

Conclusions

TRY measured immediately after ERCP provides significantly better early prediction of PEP than conventional enzymes. Rapid measurement of TRY may enable immediate risk stratification, potentially improving clinical outcomes.